company

STEINKOPF MEDICAL AS

4056 TANANGER

Return on Equity
−343,4 %
Current Ratio
2,08
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue36 248 000
Net Income−4 732 000
Total Assets2 655 000
Total Equity1 378 000
Income (NOK)2022
Revenue36 248 000
Expenditure40 725 000
Operating Profit−4 477 000
Financial Income7 000
Financial Costs262 000
Financial Balance−255 000
Earnings Before Tax−4 732 000
Tax0
Net Income−4 732 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets2 655 000
Total Assets2 655 000
Total Retained Equity378 000
Total Equity1 378 000
Total Long-Term Debt0
Total Current Debt1 278 000
Total Equity and Debt2 655 000
Cash flow (NOK)2022
Sales Income36 248 000
Other Income0
Revenue36 248 000
Cost of Goods Sold34 756 000
Salary Costs371 000
Depreciation0
Impairment0
Expenditure40 725 000
Operating Profit−4 477 000
Financial Income7 000
Financial Costs262 000
Financial Balance−255 000
Dividends0
Net Income−4 732 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock467 000
Total Investments0
Cash, Bank1 915 000
Total Current Assets2 655 000
Total Assets2 655 000
Total Equity1 378 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 182 000
Unpaid Taxes46 000
Dividends0
Other Current Debt50 000
Total Current Debt1 278 000
Total Equity and Debt2 655 000
Financial indicators2022
Return on Equity−343,4 %
Debt-to-Equity Ratio0
Operating Profit Margin−12,35 %
Current Ratio2,08
Quick Ratio3,27
Equity Ratio0,52
Gross Profit Margin4,12 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English